Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094108
Filing Date
2024-08-08
Accepted
2024-08-08 16:36:29
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20240630.htm   iXBRL 10-Q 2211150
2 EX-10.1 vera-ex10_1.htm EX-10.1 418646
3 EX-31.1 vera-ex31_1.htm EX-31.1 15548
4 EX-31.2 vera-ex31_2.htm EX-31.2 15517
5 EX-32.1 vera-ex32_1.htm EX-32.1 9189
6 EX-32.2 vera-ex32_2.htm EX-32.2 9391
7 GRAPHIC img129449286_0.jpg GRAPHIC 2751
8 GRAPHIC img129449286_1.jpg GRAPHIC 2751
9 GRAPHIC img129449286_2.jpg GRAPHIC 2751
10 GRAPHIC img129449286_3.jpg GRAPHIC 2751
  Complete submission text file 0000950170-24-094108.txt   8363733

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20240630.xsd EX-101.SCH 1060254
74 EXTRACTED XBRL INSTANCE DOCUMENT vera-20240630_htm.xml XML 1282118
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 241189083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)